0.51 USD
▲+0.02+0.02%
盘后 0.52 +1.66%
2026-08-03
市值
$96.82M
市盈率
—
EPS
-0.18
股息率
—
52 周区间
0.38 – 1.88
成交量
1.46M
Beta
1.66
目标价
2.00
52W 低 0.3852W 高 1.88
价格走势
公司简介
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emeto...